Pharma Stocks Outlook for the week – 03 to 07.04.2017
Pharma Stocks Outlook for the week – 03 to 07.04.2017
( www.rupeedesk.in )
Stocks of pharmaceutical companies are expected to be subdued next week as investors remain wary of the sector due to concerns over regulatory issues with the US Food and Drug Administration. We remain cautious of the sector in the near-term...in the long-term the growth story remains positive.
Traders expect stock-specific activity in the sector as investors are still hunting for value. Fund managers believe that the sector remains one of the only pockets offering "value" in the market. All the bad news related to the sector is in the price now of pharma stocks," said a chief strategist of a mutual fund here. The large-cap stocks are expected to underperform their mid-cap peers next week due to investors’ preference for the mid-cap space. Midcap, small cap stocks are showing a lot of momentum. Stocks of the largest drug manufacturer in the country, Sun Pharmaceutical Industries, are expected to remain rangebound next week. Dr Reddy's Laboratories' stock is expected to remain subdued, that a positive outcome from a possible inspection at the company's Srikakulam plant in Visakhapatnam could trigger a relief rally given the attractive valuation. Investors, though, will be hoping that the recent positive results for Sun Pharmaceuticals Industries' Mohali unit and Alkem Laboratories Ankalaeshwar plant could see more companies getting positive results from the US drug regulator's inspection.
Source : Cogencis Information Services Ltd
Free Intraday Tips : Join Our Whatsapp No : 9841986753
Free Commodity Tips : Join our Whatsapp No : 9094047040
Pharma Stocks Outlook for the week – 03 to 07.04.2017
( www.rupeedesk.in )
Stocks of pharmaceutical companies are expected to be subdued next week as investors remain wary of the sector due to concerns over regulatory issues with the US Food and Drug Administration. We remain cautious of the sector in the near-term...in the long-term the growth story remains positive.
Traders expect stock-specific activity in the sector as investors are still hunting for value. Fund managers believe that the sector remains one of the only pockets offering "value" in the market. All the bad news related to the sector is in the price now of pharma stocks," said a chief strategist of a mutual fund here. The large-cap stocks are expected to underperform their mid-cap peers next week due to investors’ preference for the mid-cap space. Midcap, small cap stocks are showing a lot of momentum. Stocks of the largest drug manufacturer in the country, Sun Pharmaceutical Industries, are expected to remain rangebound next week. Dr Reddy's Laboratories' stock is expected to remain subdued, that a positive outcome from a possible inspection at the company's Srikakulam plant in Visakhapatnam could trigger a relief rally given the attractive valuation. Investors, though, will be hoping that the recent positive results for Sun Pharmaceuticals Industries' Mohali unit and Alkem Laboratories Ankalaeshwar plant could see more companies getting positive results from the US drug regulator's inspection.
Source : Cogencis Information Services Ltd
